Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Part of paid clinical trials in Mountain View, California.
- Sponsor
- Envivo Bio Inc
- Study ID
- NCT06298409
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Small Intestinal Bacterial Overgrowth
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- CapScan collection capsule — DEVICEThe CapScan collection capsule is a single-use device that collects fluids from the gastrointestinal tract for analysis ex-vivo.
Study Details
We will sample intestinal microbiota using a microbiome sampling capsule in patients with Small Intestinal Bacterial Overgrowth (SIBO)
Key Dates
- Start date
- Feb 15, 2024
- Status verified
- Jun 2025
- Primary completion
- Feb 28, 2026
- Completion
- Feb 28, 2026
Study Design
- Enrollment
- 34 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Primary Outcome Measure
Sampling of gut microbiota [ Time Frame: 56 days ]
Central Contacts
- Jennifer Taufui(650) 988-7530
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Silicon Valley Gastroenterology | Mountain View | California | 94040 | Jennifer Taufui |
Find similar trials in Mountain View, CA
By research site
Related Studies
- Small Intestinal Bacterial Overgrowth: A Prospective RegistryEnrolling By Invitation · Indiana University · Indianapolis, Indiana
- Indiana University Gastrointestinal Motility Diagnosis RegistryRecruiting · Indiana University · Indianapolis, Indiana